Your cart

Ionized or Total Magnesium Levels, What Should We Measure in Critically Ill Patients?

Monitoring and measuring magnesium (Mg) values is essential to prevent the development of numerous complications in critically ill patients. This webinar will describe why Ionized Mg (iMg) may offer a more reliable indicator of Mg status during acute illness than total Mg (tMg) concentrations. Dr. Abdullah M. Al Alawi, Sr. Consultant, UMC, Muscat, Oman will discuss the incidence of dysmagnesemia and the relationship between iMg and tMg. The clinical and biochemical characteristics as well as health outcomes and their association with iMg and tMg will be addressed. Dr. Alawi will also describe the use of point-of-care devices for rapid assessment of iMg in critical situations.

PresenterPresenter: Dr. Abdullah M. Al Alawi, MD, BSc, MSc, FRACP, FACP

Sr. Consultant, UMC, Muscat, Oman
Program Director, Internal Medicine
Residency Program, Sultan Qaboos University Department of Medicine

 

PresenterPresenter: Dennis Begos, MD, FACS, FACRS

Senior Director
Medical and Scientific Affairs
Nova Biomedical

 

Hipomagnesemia en Pacientes Críticos con Insuficiencia Renal Aguda Tratados con Técnicas de Reemplazo Renal

Date: martes, 01 marzo
Time: 09:00 Hora de Europa Central, 10:00 Hora de Colombia

La hipomagnesemia es un trastorno electrolítico común en pacientes críticos y está asociado con un mayor riesgo de morbilidad y mortalidad. Muchas condiciones clínicas pueden contribuir a la hipomagnesemia a través de diferentes mecanismos patogénicos. En pacientes con lesión renal aguda (AKI), la necesidad de una terapia de reemplazo renal intermitente continua o prolongada (CKRT y PIKRT, respectivamente) puede sumarse a otras causas de hipomagnesemia, especialmente cuando se usa anticoagulación regional con citrato (RCA). La Dr. DiMario explorará estrategias destinadas a determinar con precisión cómo la adaptación precisa de las prescripciones de diálisis y la composición de los fluidos de la terapia de reemplazo renal (KRT), así como la administración temprana de suplementos de magnesio y la estrecha monitorización, podrían representar una piedra angular en la reducción de la hipomagnesemia relacionada con la KRT.

Francesca Di Mario, MD
Dipartimento Medicina Interna e Nefrologia
Az. Ospedaliero – Universitaria di Parma, Italia

Marcin Pacek, Ph.D., MBA
Scientific Director, Medical & Scientific Affairs (MASA), Europe
Nova Biomedical

Inscribirse Ahora

Hypomagnesemia in Critically Ill Patients on Kidney Replacement Therapy

Hypomagnesemia is a common electrolyte disorder in critically ill patients and is associated with increased morbidity and mortality risk. Many clinical conditions may contribute to hypomagnesemia through different pathogenetic mechanisms. In patients with acute kidney injury (AKI) the need for continuous or prolonged intermittent kidney replacement therapy (CKRT and PIKRT, respectively) may further add to other causes of hypomagnesemia, especially when regional citrate anticoagulation (RCA) is used. This webinar explores strategies aimed at how precisely tailoring both dialysis prescriptions and the composition of KRT fluids, as well as early magnesium supplementation and close monitoring of magnesium, including ionized magnesium could represent a cornerstone in reducing KRT-related hypomagnesemia.

Presenters:

Francesca Di Mario, MD

Internal Medicine and Nephrology
Parma University Medical School, Parma, Italy

Register